|
Volumn 35, Issue SUPPL. 1, 2002, Pages
|
Gene therapy and pediatric liver disease
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT DNA;
RECOMBINANT RNA;
VIRUS VECTOR;
CANCER;
CELL TRANSPLANTATION;
CLINICAL TRIAL;
CYTOLOGY;
DRUG SAFETY;
FINANCIAL MANAGEMENT;
GENE THERAPY;
GENE TRANSFER;
GENETIC SUSCEPTIBILITY;
HEALTH CARE COST;
HEALTH ECONOMICS;
HUMAN;
HUMAN CELL;
IMMUNOMODULATION;
LIVER DISEASE;
NONHUMAN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REVIEW;
RISK BENEFIT ANALYSIS;
TREATMENT OUTCOME;
CHILD;
ECONOMICS;
GENE EXPRESSION REGULATION;
GENETICS;
RESEARCH;
CHILD;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
HUMAN;
LIVER DISEASES;
RESEARCH;
HUMANS;
|
EID: 0036068976
PISSN: 02772116
EISSN: None
Source Type: Journal
DOI: 10.1097/00005176-200207001-00012 Document Type: Review |
Times cited : (6)
|
References (15)
|